Search

Danaher Corp

Lezárt

SzektorEgészségügy

230.03 0.99

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

227.15

Maximum

232.23

Fő mutatók

By Trading Economics

Bevétel

365M

1.2B

Értékesítés

289M

6.6B

P/E

Szektor átlag

38.571

50.373

Egy részvényre jutó nyereség

2.11

Osztalékhozam

0.66

Profit margin

18.843

Munkavállalók

58,000

EBITDA

-577M

1.3B

Ajánlások

By TipRanks

Ajánlások

Erős vétel

12 hónapos előrejelzés

+13.17% upside

Osztalékok

By Acuity

Osztalékhozam

Szektor átlag

0.66%

2.12%

Következő eredményjelentés

2027. jan. 27.

Következő osztalékfizetési dátum

2027. jan. 29.

Következő korábbi osztalék dátum

2026. dec. 25.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

6B

164B

Előző nyitás

229.04

Előző zárás

230.03

Danaher Corp Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. nov. 2. 23:01 UTC

News

CEO to present at UBS and Jefferies Healthcare Conferences in November.

2026. okt. 31. 00:01 UTC

Danaher Corporation's shares are trading modestly higher in after-market hours, reaching a notable high and remaining well above its 20-day moving average.

2026. okt. 30. 19:31 UTC

News
Correlated Moves

Danaher Corporation faces negative sentiment after insider transactions, including stock options exercised by executives valued at $1.23 million and $2.45 million.

2026. okt. 29. 23:41 UTC

Danaher Corporation's shares are trading higher in after-market hours, supported by a notable rise in the Life Sciences Tools & Services sub-sector.

2026. okt. 28. 23:02 UTC

Correlated Moves

Danaher Corporation is trading higher in after-market hours, reflecting strong momentum, alongside a rise in Repligen Corporation despite its recent pullback.

2026. okt. 27. 23:01 UTC

Danaher Corporation's shares are trading modestly higher in after-market hours, having peaked shortly after the market closed while remaining above its 20-day moving average.

2026. okt. 26. 23:41 UTC

Danaher Corp shares traded modestly higher during after-market hours on Monday, breaking from a recent trend of higher daily closes.

2026. okt. 24. 00:01 UTC

Danaher Corp's shares are gaining in after-market hours, recovering from a brief dip and currently positioned above its 20-day moving average.

2026. okt. 23. 23:01 UTC

Danaher Corp's shares rose slightly in after-market hours, recovering from an initial low and remaining above its 20-day moving average.

2026. okt. 22. 22:02 UTC

Correlated Moves
News

Danaher Corp reported a revenue miss due to $80M in tariff-related adjustments and raised its full-year adjusted earnings guidance amid a conservative outlook.

2026. okt. 21. 23:36 UTC

Danaher Corp's shares are modestly lower in after-market trading, retracing from a brief peak shortly after the market closed.

2026. okt. 20. 23:02 UTC

Danaher Corp declined during after-market trading, continuing a trend of four consecutive sessions closing lower amid persistent downward pressure.

2026. okt. 19. 20:01 UTC

News
Correlated Moves

Danaher Corporation is set to report third-quarter earnings on October 21, with analysts expecting $1.92 per share and $6.56 billion in revenue.

2026. okt. 17. 00:01 UTC

Danaher Corp is trading higher in after-market hours, reaching its highest cumulative return of the session and significantly above its 20-day moving average.

2026. okt. 16. 23:31 UTC

Danaher Corp shares are trading lower in after-market hours, reflecting a broader market decline amid persistent inflationary pressures indicated by today's economic data.

2026. okt. 15. 21:02 UTC

Danaher Corp shares declined modestly in after-market trading, following a volatile session that saw the stock turn lower after initial gains.

2026. okt. 14. 23:41 UTC

Danaher Corp is trading modestly higher in after-market hours, continuing a trend of five consecutive sessions of gains and remaining above its 20-day moving average.

2026. okt. 13. 23:01 UTC

Danaher Corp is trading modestly higher in after-market hours, maintaining a position well above its 20-day moving average despite notable fluctuations.

2026. okt. 12. 23:26 UTC

News

Danaher Corporation appoints Daniel L. Comas and Robert Hershberg, M.D., Ph.D., to its Board of Directors, expanding it from 11 to 13 members.

2026. okt. 9. 20:06 UTC

Correlated Moves

Danaher Corp shares are advancing, aligning with broader market gains and a rise in the life sciences sector, bolstered by positive developments at Repligen Corp.

2026. okt. 8. 23:01 UTC

Danaher Corp shares declined modestly in after-market hours, falling below Thursday's close amid unusual trading behavior and remaining in the middle of its one-month range.

2026. okt. 7. 23:00 UTC

Danaher Corp's shares traded lower in after-market hours, declining before slightly recovering, while remaining near the middle of their one-month trading range.

2026. okt. 6. 22:21 UTC

Danaher Corp's shares advanced modestly in after-market hours, reflecting broader market gains and positioning above its 20-day moving average.

2026. okt. 5. 23:15 UTC

Danaher Corp's shares are trading modestly lower in after-market hours, down from Monday's close despite a minor recovery earlier in the session.

2026. okt. 2. 20:03 UTC

Danaher Corp is advancing, continuing its upward trend since Thursday's close, despite pulling back from an earlier session high.

2026. okt. 1. 23:35 UTC

Danaher Corp is trading slightly lower in after-market hours, extending a trend of declines over the past four consecutive sessions.

2026. szept. 30. 23:00 UTC

Danaher Corp has advanced in after-market trading, moving significantly higher from a flat start and positioned well above its 20-day moving average.

2026. szept. 29. 20:21 UTC

Danaher Corp is trading modestly lower in after-market hours, declining after an initial uptick, despite being above its 20-day moving average.

2026. szept. 28. 23:01 UTC

Danaher Corp's shares are trading modestly lower in after-market hours, continuing a decline since Monday's close and remaining at their lowest point during this session.

2026. szept. 26. 00:01 UTC

Danaher Corp is declining in after-market trading, moving lower since Friday's close, ending a streak of five consecutive higher sessions.

Társak összehasonlítása

Árváltozás

Danaher Corp Előrejelzés

Célár

By TipRanks

13.17% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 258 USD  13.17%

Magas 275 USD

Alacsony 210 USD

13 Wall Street elemző 12 hónapos célárain alapulva a(z)Danaher Corp termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Erős vétel

13 ratings

13

Vétel

0

Tartás

0

Eladás

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Danaher Corp

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a research collaboration with Stanford University's Department of Bioengineering for cancer drug development. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.
help-icon Live chat